Taiwan FDA registration 094d62352f7f22f187db635d65e1c0b5
KatiaTM ENA Joint Screening Group
TW: 卡蒂雅TM ENA聯合篩選組
Taiwan·Risk Class 2·TRINITY BIOTECH USA·Registered Aug 10, 2006 – Aug 10, 2011CancelledRegistration details
- Analysis ID
- 094d62352f7f22f187db635d65e1c0b5
- Customs Code
- DHA00601727402
Company information
- Manufacturer
- TRINITY BIOTECH USA
- Manufacturer Country
- United States
- Authorized Representative
- GRAND MARQUIS CO., LTD.
Product details
- Intended Use
- Enzyme immunosorption analysis was used to detect ENA antigen in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5100 抗核抗體免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Aug 10, 2006
- Expiry Date
- Aug 10, 2011
- Cancellation Date
- Nov 27, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for KatiaTM ENA Joint Screening Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 094d62352f7f22f187db635d65e1c0b5 and manufactured by TRINITY BIOTECH USA. The authorized representative in Taiwan is GRAND MARQUIS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices